[ad_1]
NEW DELHI: The Department of pharmaceuticals (DoP) has raised concerns over complaints of “indiscriminate” use of anti-viral drug remdesivir in hospitals which is resulting in shortage of the drug in
AbcSmall
AbcMedium
AbcLarge
Access the exclusive Economic Times stories, Editorial and Expert opinion
Already a Member? Sign In now
Sharp Insight-rich, Indepth stories across 20+ sectors
Access the exclusive Economic Times stories, Editorial and Expert opinion
Minimal Ads
[ad_2]
Source link